Market Cap N/A
Revenue (ttm) 390.40M
Net Income (ttm) -11.93M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin -3.06%
Debt to Equity Ratio N/A
Volume 2,821,941
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founde...

Industry: Health Information Services
Sector: Healthcare
Phone: 415 726 2206
Address:
455 Market Street, Suite 700, San Francisco, United States
erevnon
erevnon Mar. 11 at 2:50 PM
RBC Capital maintains Hinge Health $HNGE at Outperform and raises the price target from $50 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
Breck100
Breck100 Mar. 10 at 5:55 PM
$HNGE 3/10/26 Hinge Health, Inc. Class A (HNGE) Jailendra Singh from Truist Financial reiterated a Buy rating on Hinge Health, Inc. Class A, with a price target of $63.00. The company’s shares closed last Monday at $45.99.
0 · Reply
healthcareguru
healthcareguru Mar. 9 at 3:17 PM
$HNGE this is a joke…zero competitive moat, AI risk, and insanely overvalued. 👎
1 · Reply
jpcalm68
jpcalm68 Feb. 25 at 3:24 PM
$BBIO $TARS $HNGE 3 Bio tech companies with bright futures.
0 · Reply
Stock_Wahab
Stock_Wahab Feb. 23 at 5:45 PM
$HNGE Wait till you see the so called president and CFO has been selling hand over fist as well.
0 · Reply
MarketRegimes
MarketRegimes Feb. 20 at 2:09 PM
$HNGE Henge Holdings is a low-liquidity microcap. Price action often disconnects from fundamentals. Risk control is essential.
0 · Reply
Ezz77
Ezz77 Feb. 19 at 5:59 PM
$HNGE no wonder this dropped down to the low 30s and can’t hold 40. Apparently the ceo has sold 500,000 shares in 2026 worth 23M, average daily volume is 2.4M, consistently selling pressure. CEO also has 9M shares or roughly 10 percent of the company and has 250M share buyback program so can even out but still can’t be helping the price when this has such a small retail following a lot buyers don’t step in to counter act selling pressure, unless hnge is using buyback program.
1 · Reply
healthcareguru
healthcareguru Feb. 19 at 3:29 PM
$HNGE going right back to <$30…this business is absolutely silly to me. Def an AI structural risk.
1 · Reply
6GodEnergy
6GodEnergy Feb. 17 at 6:31 PM
$GNRC $AMSC $HNGE $CMPS •€•*
0 · Reply
6GodEnergy
6GodEnergy Feb. 17 at 4:13 PM
0 · Reply
Latest News on HNGE
Why Is Hinge Health Stock Soaring Wednesday?

Feb 11, 2026, 7:01 AM EST - 4 weeks ago

Why Is Hinge Health Stock Soaring Wednesday?


Hinge Health, Inc. (HNGE) Q4 2025 Earnings Call Transcript

Feb 10, 2026, 8:54 PM EST - 4 weeks ago

Hinge Health, Inc. (HNGE) Q4 2025 Earnings Call Transcript


Hinge Health Reduces MRIs and X-Rays for Back Pain by 60%

Nov 24, 2025, 11:00 AM EST - 3 months ago

Hinge Health Reduces MRIs and X-Rays for Back Pain by 60%


Hinge Health announces $250 million share repurchase program

Nov 12, 2025, 9:00 AM EST - 4 months ago

Hinge Health announces $250 million share repurchase program


Hinge Health, Inc. (HNGE) Q3 2025 Earnings Call Transcript

Nov 4, 2025, 9:16 PM EST - 4 months ago

Hinge Health, Inc. (HNGE) Q3 2025 Earnings Call Transcript


Hinge Health reports third quarter 2025 financial results

Nov 4, 2025, 4:05 PM EST - 4 months ago

Hinge Health reports third quarter 2025 financial results


Hinge Health unveils new AI-powered care tools

Oct 21, 2025, 11:00 AM EDT - 5 months ago

Hinge Health unveils new AI-powered care tools


Hinge Health CEO on Q2 earnings since IPO, AI usage and growth

Aug 5, 2025, 4:53 PM EDT - 7 months ago

Hinge Health CEO on Q2 earnings since IPO, AI usage and growth


Hinge Health Reports Second Quarter 2025 Financial Results

Aug 5, 2025, 4:05 PM EDT - 7 months ago

Hinge Health Reports Second Quarter 2025 Financial Results


Hinge Health: Huge Growth Potential

Jul 21, 2025, 10:49 AM EDT - 8 months ago

Hinge Health: Huge Growth Potential


IPO Filings Remain Low In Q2

Jun 3, 2025, 2:35 AM EDT - 10 months ago

IPO Filings Remain Low In Q2

CHYM KLAR META MNTN STUB


Hinge Health: I Have A Positive Hinge On This Offering

May 23, 2025, 12:22 PM EDT - 10 months ago

Hinge Health: I Have A Positive Hinge On This Offering


Hinge Health pops 17%, but joins growing ranks of down round IPOs

May 22, 2025, 5:58 PM EDT - 10 months ago

Hinge Health pops 17%, but joins growing ranks of down round IPOs


Hinge Health Goes Public, Raising $437M for Investors

May 22, 2025, 3:19 PM EDT - 10 months ago

Hinge Health Goes Public, Raising $437M for Investors


Insight Partners-backed Hinge Health shares jump in New York debut

May 22, 2025, 1:08 PM EDT - 10 months ago

Insight Partners-backed Hinge Health shares jump in New York debut


Hinge Health raises $437.3 million in US IPO

May 21, 2025, 7:15 PM EDT - 10 months ago

Hinge Health raises $437.3 million in US IPO


Hinge Health prices IPO at $32, the top end of expected range

May 21, 2025, 6:26 PM EDT - 10 months ago

Hinge Health prices IPO at $32, the top end of expected range


Hinge Health Announces Pricing of Initial Public Offering

May 21, 2025, 6:21 PM EDT - 10 months ago

Hinge Health Announces Pricing of Initial Public Offering


Hinge Health Aims to Raise $437 Million in IPO

May 13, 2025, 1:00 PM EDT - 10 months ago

Hinge Health Aims to Raise $437 Million in IPO


Hinge Health Announces Launch of Initial Public Offering

May 13, 2025, 8:40 AM EDT - 10 months ago

Hinge Health Announces Launch of Initial Public Offering


Hinge Health targets $2.6 billion valuation in NYSE IPO

May 13, 2025, 6:46 AM EDT - 10 months ago

Hinge Health targets $2.6 billion valuation in NYSE IPO


Hinge Health Pursues IPO On High Revenue Growth

Mar 12, 2025, 1:04 PM EDT - 1 year ago

Hinge Health Pursues IPO On High Revenue Growth


erevnon
erevnon Mar. 11 at 2:50 PM
RBC Capital maintains Hinge Health $HNGE at Outperform and raises the price target from $50 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
Breck100
Breck100 Mar. 10 at 5:55 PM
$HNGE 3/10/26 Hinge Health, Inc. Class A (HNGE) Jailendra Singh from Truist Financial reiterated a Buy rating on Hinge Health, Inc. Class A, with a price target of $63.00. The company’s shares closed last Monday at $45.99.
0 · Reply
healthcareguru
healthcareguru Mar. 9 at 3:17 PM
$HNGE this is a joke…zero competitive moat, AI risk, and insanely overvalued. 👎
1 · Reply
jpcalm68
jpcalm68 Feb. 25 at 3:24 PM
$BBIO $TARS $HNGE 3 Bio tech companies with bright futures.
0 · Reply
Stock_Wahab
Stock_Wahab Feb. 23 at 5:45 PM
$HNGE Wait till you see the so called president and CFO has been selling hand over fist as well.
0 · Reply
MarketRegimes
MarketRegimes Feb. 20 at 2:09 PM
$HNGE Henge Holdings is a low-liquidity microcap. Price action often disconnects from fundamentals. Risk control is essential.
0 · Reply
Ezz77
Ezz77 Feb. 19 at 5:59 PM
$HNGE no wonder this dropped down to the low 30s and can’t hold 40. Apparently the ceo has sold 500,000 shares in 2026 worth 23M, average daily volume is 2.4M, consistently selling pressure. CEO also has 9M shares or roughly 10 percent of the company and has 250M share buyback program so can even out but still can’t be helping the price when this has such a small retail following a lot buyers don’t step in to counter act selling pressure, unless hnge is using buyback program.
1 · Reply
healthcareguru
healthcareguru Feb. 19 at 3:29 PM
$HNGE going right back to <$30…this business is absolutely silly to me. Def an AI structural risk.
1 · Reply
6GodEnergy
6GodEnergy Feb. 17 at 6:31 PM
$GNRC $AMSC $HNGE $CMPS •€•*
0 · Reply
6GodEnergy
6GodEnergy Feb. 17 at 4:13 PM
0 · Reply
stockpicker63
stockpicker63 Feb. 14 at 11:55 AM
Our SST system showed us the way — but it definitely required hard work. Best trades this week: $WULF +16% $GXO +9% $HNGE +8% $HUBS +7% $RACE +7.5% All trades are available on the site.
1 · Reply
RainyDayFund
RainyDayFund Feb. 12 at 7:11 PM
$HNGE Nice ER. Hoping to get back to B/E soon
0 · Reply
jpcalm68
jpcalm68 Feb. 12 at 6:08 PM
$BBIO $HNGE and $TARS are my three healthcare plays. Always target the top shelf companies.
0 · Reply
Ezz77
Ezz77 Feb. 12 at 5:37 PM
$HNGE some nice strength for a bloody day, should be in the 40s soon
0 · Reply
TheBullishTrade
TheBullishTrade Feb. 12 at 4:57 PM
$HNGE $FSLY U have to be selective with these earning reporters. They are very trick this time
0 · Reply
tarded
tarded Feb. 12 at 2:34 PM
$HNGE LAST TIME YOU WILL EVER SEE 40 AGAIN
0 · Reply
greczarfalco
greczarfalco Feb. 12 at 8:16 AM
$HNGE only company really using AI
0 · Reply
DailyAnalysis
DailyAnalysis Feb. 11 at 6:51 PM
$HNGE 1W structure is weak with 1D RSI at 57. Monitoring 4H STOCH for a crossover to validate the 30M CCI recovery. Strategic positioning is required as long-term moving averages act as resistance. @DailyAnalysis
0 · Reply
Ezz77
Ezz77 Feb. 11 at 6:00 PM
$HNGE hnge got 80 on the rule of 40 for 2025… and only 700 retail followers, wild. $PLTR alex karp knows 80 ain’t east. #crosspost 😂
0 · Reply
Breck100
Breck100 Feb. 11 at 3:53 PM
0 · Reply
Ezz77
Ezz77 Feb. 11 at 3:45 PM
$HNGE they guide for 171-173M q1, but on Stocktwits estimated for q1 is 165…. lol come on now
0 · Reply
Jasooon
Jasooon Feb. 11 at 3:20 PM
$HNGE hell yeah. Great ER and the analysts agree:
0 · Reply